Working… Menu

Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults (MTBVAC-Ph1b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02729571
Recruitment Status : Completed
First Posted : April 6, 2016
Last Update Posted : May 1, 2018
South African Tuberculosis Vaccine Initiative
TuBerculosis Vaccine Initiative
Triclinium Clinical Trial Project Management (Pty) Ltd.
Universidad de Zaragoza
Information provided by (Responsible Party):
Biofabri, S.L

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2016
Actual Study Completion Date : March 2018
Publications automatically indexed to this study by Identifier (NCT Number):